Vir Biotechnology, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vir Biotechnology, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2020 to Q3 2024.
  • Vir Biotechnology, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $60.8M, a 16.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $60.8M -$11.8M -16.3% Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $62.3M -$12.7M -16.9% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $70.3M -$11.2M -13.7% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $71.2M -$11.4M -13.8% Dec 31, 2023 10-Q 2024-11-04
Q3 2023 $72.6M -$12.1M -14.3% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $74.9M -$11.9M -13.7% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $81.5M -$6.83M -7.73% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $82.6M -$4.66M -5.35% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $84.7M +$27.2M +47.2% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $86.9M +$27.9M +47.3% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $88.3M +$27.9M +46.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $87.2M +$25.3M +40.8% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $57.6M +$42.8M +290% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $59M +$43.8M +289% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $60.5M +$44.5M +278% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $61.9M Dec 31, 2020 10-K 2022-02-28
Q3 2020 $14.8M Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $15.2M Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $16M Mar 31, 2020 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.